Nutriband/$NTRB
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Nutriband
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. Company operates in two reportable segments namely, Sales of Goods and Services. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
- Ticker
- $NTRB
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- -
- Headquarters
- Orlando, United States
- Website
- www.nutriband.com
Nutriband Metrics
BasicAdvanced
$70M
-
-$0.57
2.04
-
Price and volume
Market cap
$70M
Beta
2.04
52-week high
$9.19
52-week low
$2.80
Average daily volume
36K
Financial strength
Current ratio
4.211
Quick ratio
3.798
Long term debt to equity
0.011
Total debt to equity
0.041
Interest coverage (TTM)
-255.59%
Profitability
EBITDA (TTM)
-6.9
Gross margin (TTM)
33.14%
Net profit margin (TTM)
-430.43%
Operating margin (TTM)
-435.57%
Management effectiveness
Return on assets (TTM)
-53.48%
Return on equity (TTM)
-100.75%
Valuation
Price to revenue (TTM)
43.2
Price to book
13.15
Price to tangible book (TTM)
20.38
Price to free cash flow (TTM)
-19.239
Free cash flow yield (TTM)
-5.20%
Free cash flow per share (TTM)
-0.299
Growth
Revenue change (TTM)
-37.25%
Earnings per share change (TTM)
-80.08%
3-year revenue growth (CAGR)
-10.79%
3-year earnings per share growth (CAGR)
-0.12%
Nutriband Financial Performance
Revenues and expenses
Nutriband Earnings Performance
Company profitability
Upcoming events
No upcoming events
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.